| Product Name | Ticagrelor-d7 |
| Product Code | DA-T087-ak |
| Chemical name | Ticagrelor-d7 |
| Synonyms | (1S,2S,3R,5S)-3-[7-[[(1R,2S)-2-(3,4-D1,2-Cyclopentanediol ifluorophenyl)cyclopropyl]amino]-5-(propylthio-d7)-3H-1,2,3-triazolo[4,5-d]pyrimidin-3-yl]-5-(2-hydroxyethoxy)-1,2-cyclopentanediol; AR-C 126532XX-d7; AZD 6140-d7; |
| Impurity | NA |
| CAS Number | 1265911-55-4 |
| Alternate CAS # | NA |
| Molecular form | C23H21D7F2N6O4S |
| Appearance | Yellow Solid |
| Melting Point | NA |
| Mol. Weight | 529.61 |
| Storage | 2-8°C Refrigerator |
| Solubility | NA |
| Stability | NA |
| Category | aromatics,heterocycles,pharmaceutical standards,intermediates,fine chemicals,sulphur and selenium compounds,stable isotopes |
| Boiling Point | NA |
| Applications | Labelled Ticagrelor, the first reversible oral P2Y12 receptor antagonist, provides faster, greater, and more consistent ADP-receptor inhibition than Clopidogrel. Used in the treatment of acute coronary syndromes (ACS). |
| Dangerous Goods Info | NA |
| References | NA |
| Extra Notes | NA |
| Documents (MSDS) | No Data Available |
| Keywords | NA |
